News

Our reputation as a national leader in the field of prosecuting class action, commercial litigation, and qui tam cases makes headlines and shapes precedent across the country. Major media outlets and industry publications regularly consult Berger Montague lawyers as knowledgeable and insightful sources to comment on regulation, legislation, precedent-setting cases, and industry developments. To learn about the most recent activities of the firm and its attorneys, read on. If you are a member of the news media seeking to develop a story concerning a legal subject or newsworthy case, please contact Caroline Cornell at 925-301-5660 or [email protected] or contact Melania Stepanenko at [email protected]

Berger Montague Kicks Off 2023 By Appointing Three New Shareholders: William Ellerbe, Hans Lodge, and Michaela Wallin

Berger Montague is proud to welcome three new shareholder attorneys to its ranks: William Ellerbe, Hans Lodge, and Michaela Wallin. The new shareholders represent a broad array of practice areas and skills, and Berger Montague is pleased that the promotions, all from within, reflect the firm’s internal mentoring processes and dedication to creating opportunities for all lawyers at the firm.

Securities Class Action: Y-mAbs Therapeutics, Inc.

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) on behalf of those who purchased Y-mAbs common stock between October 6, 2020 through October 28, 2022.

  • January 20, 2023
  • Securities & Investor Protection
  • Read More >

Securities Class Action: Tattooed Chef, Inc.

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Tattooed Chef, Inc. (“Tattooed Chef”) (NASDAQ: TTCF) on behalf of those who purchased Tattooed Chef securities between March 20, 2021 and October 12, 2022, inclusive (the “Class Period”).

  • January 4, 2023
  • Securities & Investor Protection
  • Read More >

Securities Class Action: Daktronics Inc.

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Daktronics, Inc. (“Daktronics”) (NASDAQ: DAKT) on behalf of those who purchased Daktronics securities between March 10, 2022 and December 6, 2022 inclusive (the “Class Period”).

  • December 23, 2022
  • Securities & Investor Protection
  • Read More >

Merrill Davidoff and Todd Collins Retire After Decades-Long Commitment to American Investors, Employees, and Consumers

Berger Montague Chairman Emeritus and Executive Shareholder Merrill G. Davidoff, and Executive Shareholder and General Counsel Todd Collins are retiring at the end of this year after serving the firm for a combined 90 years. Shareholder Marty Twersky also announces his retirement.

Securities Class Action: Spectrum Pharmaceuticals, Inc.

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (“Spectrum”) (NASDAQ: SPPI) on behalf of those who purchased Spectrum common stock during the period December 6, 2021 through September 22, 2022, inclusive (the “Class Period”).

  • December 12, 2022
  • Securities & Investor Protection
  • Read More >

Singularity Future Technology Ltd. Class Action

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Singularity Future Technology Ltd. (NASDAQ: SGLY) f/k/a Sino-Global Shipping America Ltd. (NASDAQ: SINO) (“Singularity”) on behalf of those who purchased Singularity securities between February 12, 2021 and November 17, 2022, inclusive (the “Class Period”).

Securities Class Action: Iris Energy LTD.

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Iris Energy Limited (“Iris”) (NASDAQ: IREN) on behalf of those who purchased: (a) Iris ordinary shares pursuant and/or traceable to Iris’s initial public offering conducted on or about November 17, 2021 (the “IPO”); and/or (b) Iris securities between November 17, 2021 and November 1, 2022, both dates inclusive (the “Class Period”).

  • December 8, 2022
  • Securities & Investor Protection
  • Read More >

Securities Class Action: NeoGenomics, Inc.

Berger Montague advises investors that a securities fraud class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics”) (NASDAQ: NEO) on behalf of those who purchased publicly traded NeoGenomics, Inc. securities between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”).

  • December 7, 2022
  • Securities & Investor Protection
  • Read More >

Berger Montague Clients File Class Action Against Anthem

Berger Montague announces that a class action complaint has been filed alleging that network access provider Anthem, recently rebranded as Elevance, unlawfully refuses to allow self-funded health plans with which it contracts to access their own plan claims data in violation of federal laws.

Go to page: 1 2 3 31

Request A Free Consultation